Hero

EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH

cachedupdated
apps

Key Facts

insert_link

This company profile is a search result of implisense.com

Register your Implisense account for free

Register now for a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.

  • content_copy
    Richer Company Profiles
  • search
    Expanded Search Results
  • star_border
    Personal Favourites and Notes
explore

Network

insert_link
An extensive interactive company network is available in Implisense Plus. This takes into account legal connections, connections via shared management as well as links between company websites. A simplified form of this network will also be publicly available soon.
linear_scale

Timeline

insert_link
Funding
Beginn des Förderprojektes "Wirkstofftransport: Entwicklung von tumorselektiven Radiotherapeutika Prodrugs für die nuklearmedizinische Therapie von Glioblastomen (GLIOTAR) - In-vitro- und In-vivo-Studien mit Prodrug-Kandidaten" (BMBF 16GW0312)

Heute startet das Förderprojekt "Wirkstofftransport: Entwicklung von tumorselektiven Radiotherapeutika Prodrugs für die nuklearmedizinische Therapie von Glioblastomen (GLIOTAR) - In-vitro- und In-vivo-Studien mit Prodrug-Kandidaten". Es wird vom BMBF unter dem Förderkennzeichen 16GW0312 für die EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH mit einer Summe von 313.588,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.

Funding
Beginn des Förderprojektes "Wirkstofftransport: Paclitaxel-beladene polymere Mizellen (Pizellen) für die Behandlung von Triple-negativem Brustkrebs (PP-TNBC) - In vivo Studien zur Wirksamkeit und Pharmakologie von Pizellen in TNBC PDX-Modellen" (BMBF 16GW0321)

Heute startet das Förderprojekt "Wirkstofftransport: Paclitaxel-beladene polymere Mizellen (Pizellen) für die Behandlung von Triple-negativem Brustkrebs (PP-TNBC) - In vivo Studien zur Wirksamkeit und Pharmakologie von Pizellen in TNBC PDX-Modellen". Es wird vom BMBF unter dem Förderkennzeichen 16GW0321 für die EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH mit einer Summe von 103.446,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.

Register Filings
Veränderung im Handelsregister

Prokura: 1. Prof. Dr. Walter, Wolfgang, *XX.XX.XXXX, Panketal; Einzelprokura mit der Befugnis Rechtsgeschäfte als Vertreter Dritter abzuschließen

Funding
Abschluss des Förderprojektes "ERA-NET EuroTransBio-10: MetaDiC - Unter Verwendung eines neuartigen Verfahrens werden gezielt krebsrelevante Kandidatengene in Patienten-abgeleiteten Pankreaskarzinomen ausgeschaltet. Das Projekt beinhaltet die Validierung bisher nicht verfügbare Modellsysteme sowie die Identifizierung diagnostischer Biomarker" (BMBF 031B0093A)

Heute endet das Förderprojekt "ERA-NET EuroTransBio-10: MetaDiC - Unter Verwendung eines neuartigen Verfahrens werden gezielt krebsrelevante Kandidatengene in Patienten-abgeleiteten Pankreaskarzinomen ausgeschaltet. Das Projekt beinhaltet die Validierung bisher nicht verfügbare Modellsysteme sowie die Identifizierung diagnostischer Biomarker". Es wurde vom BMBF unter dem Förderkennzeichen 031B0093A für die EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH mit einer Summe von 256.154,00 Euro gefördert. Die Laufzeit des Projektes betrug 48 Monate.

Funding
Abschluss des Förderprojektes "ERA NET Eurotransbio10: HUMIC: Entwicklung humanisierter Modellsysteme für die (immunonkologische) Medikamentenentwicklung, die auf einer Kombination von 3D-Zellkultursystemen und patientenabgeleiteten Xenograftmodellen (PDX) basieren." (BMBF 031B0108)

Heute endet das Förderprojekt "ERA NET Eurotransbio10: HUMIC: Entwicklung humanisierter Modellsysteme für die (immunonkologische) Medikamentenentwicklung, die auf einer Kombination von 3D-Zellkultursystemen und patientenabgeleiteten Xenograftmodellen (PDX) basieren.". Es wurde vom BMBF unter dem Förderkennzeichen 031B0108 für die EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH mit einer Summe von 236.476,00 Euro gefördert. Die Laufzeit des Projektes betrug 36 Monate.

assessment

Products & Services

insert_link
Prädiktive Analysen
Screening
Drug Development
Fulfillment
Drug Design
PCR
Peptide
Translation
Compounds

EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH is mentioned in public sources in the context of the following products and services. Prädiktive Analysen, Screening and Drug Development are the most common. The ranking list shown is without guarantee of completeness or correctness.

spa

Value Profile

insert_link
Dominance, Competence, ClarityInnovation, Passion, CreativityHarmony, Reliability, CommunicatibilityDilligence, Introspection, Thoroughness
Dominance, Competence, Clarity
Innovation, Passion, Creativity
Harmony, Reliability, Communicatibility
Dilligence, Introspection, Thoroughness

The 4 Color Scheme separates people and their personalities into four groups. EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH emphasizes the following character types in their external communications and job advertisements.

You can find more information on the FAQ page.

assignment_turned_in

Requirements for Job Seekers

insert_link

Based on job advertisements of EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH, the following specific requirements for job seekers were identified more frequently. Very common requirements are Beharrlichkeit, Soziale Kompetenz and Sorgfalt. Specific requirements can be found in the latest published job advertisements.

code

Integration via API

insert_link
content_copy
  1. curl \
  2. --silent \
  3. --request GET \
  4. --header "Content-Type: application/json" \
  5. --url "https://implisen.se/DEZ8IIKJMU02" | jq '.'
play_arrow
  •  
content_copy
  1. require 'json'
  2. require 'net/http'
  3. uri = URI('https://implisen.se/DEZ8IIKJMU02')
  4. response = Net::HTTP.get(uri)
  5. puts JSON.parse(response)
play_arrowcontent_copy
  •  
content_copy
  1. const https = require('https');
  2. https.get('https://implisen.se/DEZ8IIKJMU02', (response) => {
  3. let data = '';
  4. response.on('data', (chunk) => {
  5. data += chunk;
  6. });
  7. response.on('end', () => {
  8. console.log(JSON.parse(data));
  9. });
  10. });
play_arrowcontent_copy
  •  
content_copy
  1. import urllib.request
  2. import json
  3. from pprint import pprint
  4. response = urllib.request.urlopen('https://implisen.se/DEZ8IIKJMU02').read()
  5. pprint(json.loads(response))
play_arrowcontent_copy
  •  
content_copy
  1. package main
  2. import( "net/http"
  3. "io/ioutil"
  4. "bytes"
  5. "encoding/json"
  6. "fmt"
  7. func main() {
  8. response, _ := http.Get("https://implisen.se/DEZ8IIKJMU02")
  9. defer response.Body.Close()
  10. payload, _ := ioutil.ReadAll(response.Body)
  11. var out bytes.Buffer
  12. json.Indent(&out, payload, "", " ")
  13. fmt.Println(string(out.Bytes()))
play_arrowcontent_copy
  •  

With the Implisense API you can enrich your CRM or ERP system with public data on over 2 million companies. Via the RapidAPI marketplace you can directly access our API. For further information, please refer to our internal page on the Implisense API.

Register your Implisense account for free

Register now for a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.

  • content_copy
    Richer Company Profiles
  • search
    Expanded Search Results
  • star_border
    Personal Favourites and Notes
more_horiz

You may also be interested in

insert_link
bookmark_border
location_cityReutlingen
workResearch & Development (M72)
bookmark_border
location_cityHamburg
workResearch & Development (M72)
bookmark_border
location_cityGräfelfing
workPharmacy (C21)
bookmark_border
location_cityHamburg
workResearch & Development (M72)
bookmark_border
location_cityDüsseldorf
workResearch & Development (M72)
bookmark_border
location_cityAugsburg
workResearch & Development (M72)
bookmark_border
location_cityHeidelberg
workResearch & Development (M72)
bookmark_border
location_cityDresden
workResearch & Development (M72)
bookmark_border
location_cityHennigsdorf
workResearch & Development (M72)
bookmark_border
location_cityBonn
workResearch & Development (M72)
The company information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all